Aigen Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Aigen Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-21,270	Closed	-$243K	–	851
2023 Q4	$243K	Buy	21,270 +7,833	+58%	+$77.5K	0.04%	581
2023 Q3	$129K	Buy	+13,437	New	+$132K	0.02%	724
2023 Q2	–	Sell	-31,893	Closed	-$336K	–	866
2023 Q1	$336K	Sell	31,893 -9,194	-22%	-$103K	0.05%	404
2022 Q4	$509K	Buy	+41,087	New	+$466K	0.07%	266
2022 Q1	–	Sell	-13,458	Closed	-$157K	–	810
2021 Q4	$157K	Buy	+13,458	New	+$165K	0.01%	963
2020 Q3	–	Sell	-20,581	Closed	-$212K	–	983
2020 Q2	$212K	Sell	20,581 -47,837	-70%	-$490K	0.03%	696
2020 Q1	$690K	Sell	68,418 -16,308	-19%	-$192K	0.09%	321
2019 Q4	$1.13M	Buy	+84,726	New	+$934K	0.19%	153

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Aigen Investment Management's IRWD Position: Q1 2024 in Review

Aigen Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 21,270 shares — an estimated $243K sold.

Aigen Investment Management first reported a position in IRWD in Q4 2019 and held it in 8 quarters. The position peaked at $1.13M in Q4 2019. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

Aigen Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Aigen Investment Management sold 21,270 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $243K.
Aigen Investment Management first reported a position in Ironwood Pharmaceuticals in Q4 2019 and held it in 8 quarters.
Aigen Investment Management's Ironwood Pharmaceuticals position peaked at $1.13M in Q4 2019.
261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on Aigen Investment Management's 13F filing for Q1 2024, filed 14 May 2024.